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Interpretive summary: Effect of a whey protein and rapeseed oil gel feed supplement on 1 
milk fatty acid composition of Holstein cows 2 
Kliem 3 
Supplementing dairy cow diets with rapeseed oil decreases saturated and increases 4 
monounsaturated fatty acids in milk fat. To maximise this effect (and to minimise trans fatty 5 
acids), the oil needs to be protected from the cow rumen. This study investigated the use of 6 
supplemental lipid-protein gels of rapeseed oil, to improve milk fatty acid profile. The 7 
supplements were effective at achieving this. 8 
 9 
WHEY PROTEIN GEL OF RAPESEED OIL 10 
 11 
Effect of a whey protein and rapeseed oil gel feed supplement on milk fatty acid 12 
composition of Holstein cows  13 
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ABSTRACT 36 
Isoenergetic replacement of dietary saturated fatty acids (SFA) with cis-monounsaturated fatty 37 
acids (MUFA) and polyunsaturated fatty acids (PUFA) can reduce cardiovascular disease 38 
(CVD) risk. Supplementing dairy cow diets with plant oils lowers milk fat SFA concentrations. 39 
However, this feeding strategy can also increase milk fat trans FA (TFA), and negatively 40 
impact rumen fermentation. Protection of oil supplements from the rumen environment is 41 
therefore needed. In the present study a whey protein gel (WPG) of rapeseed oil (RO) was 42 
produced for feeding to dairy cows, in two experiments. In Experiment 1 four multiparous 43 
Holstein-Friesian cows in mid-lactation were used in a change-over experiment, with 8-d 44 
treatment periods separated by a 5-day washout period. Total mixed ration diets containing 420 45 
g RO or WPG providing 420 g of RO were fed and the effects on milk production, composition 46 
and FA concentration were measured. Experiment 2 involved four multiparous mid-lactation 47 
Holstein-Friesian cows in a 4 x 4 Latin square design experiment, with 28-d periods, to 48 
investigate the effect of incremental dietary inclusion (0, 271, 617 and 814 g/d supplemental 49 
oil) of WPG on milk production, composition and FA concentration in the last week of each 50 
3 
 
period. There were minimal effects of WPG on milk FA profile in experiment 1, but trans-18:1 51 
and total trans-MUFA were higher after 8 days of supplementation with RO than with WPG. 52 
Incremental diet inclusion of WPG in experiment 2 resulted in linear increases in milk yield, 53 
cis- and trans-MUFA and PUFA, and linear decreases in SFA (from 73 to 58 g/100 g FA), and 54 
milk fat concentration. The WPG supplement was effective at decreasing milk SFA 55 
concentration by replacement with MUFA and PUFA in experiment 2, but the increase in TFA 56 
suggested that protection was incomplete.  57 
 58 
INTRODUCTION 59 
There is evidence that cardiovascular disease (CVD) risk can be reduced by the isoenergetic 60 
replacement of saturated fatty acids (SFA) with cis-monounsaturated fatty acids (MUFA) or 61 
polyunsaturated fatty acids (PUFA) in the human diet (Vafeiadou et al., 2015). In the United 62 
Kingdom, milk and dairy products contribute about 25 and 28 % of total SFA consumed by 63 
men and women, respectively (Bates et al., 2014), with higher contributions in other countries 64 
(Hulshof et al., 1999). Altering the fatty acid (FA) composition of milk and dairy products by 65 
replacing SFA with MUFA offers an opportunity to lower SFA intake while maintaining the 66 
contribution of these foods to the balanced human diet.  67 
 68 
Plant oil supplements are an effective dietary strategy to decrease milk fat SFA concentrations, 69 
by replacement with cis-MUFA (Kliem and Shingfield, 2016).  However, cis-MUFA-rich plant 70 
oils (such as rapeseed) and oilseed preparations can undergo biohydrogenation/isomerisation 71 
(both of cis-9 18:1, and also 18:2 n-6 and 18:3 n-3) in the rumen leading to the formation of 72 
trans-double bond containing intermediates (Harfoot and Hazlewood, 1997, McKain et al., 73 
2010). Other studies using rapeseed supplements to replace milk fat SFA with cis-MUFA, also 74 
reported concomitant increases in trans-fatty acids (TFA; Givens et al., 2009, Kliem et al., 75 
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2011). These comprise of mainly trans-18:1 isomers, and smaller quantities of trans-containing 76 
non-conjugated 18:2 isomers. At current human intake levels ruminant-derived TFA (rTFA) 77 
are thought not to have negative effects on human health (Mozaffarian, 2006), although further 78 
research is required to inform on the isomer-specific effects of rTFA (Gebauer et al., 2011). 79 
Prospective studies have proved inconsistent, with some associating rTFA intake with 80 
increased CVD risk in women (Laake et al., 2012), and others reporting no such association 81 
(Bendsen et al., 2011). A meta-analysis of thirteen clinical studies reported that there was no 82 
effect of rTFA on certain risk factors of CVD with intakes up to 4.19 % energy intake (Gayet-83 
Boyer et al., 2014). However, as rTFA and industrially-derived TFA are 40% similar in terms 84 
of isomer profile (Mensink and Nestel, 2009), and with mandatory food labelling for trans fats 85 
in the USA, and legislation to minimise trans fats in food (Denmark, Austria, Hungary, Latvia), 86 
efforts should be sought to protect any supplemental unsaturated oils from rumen 87 
biohydrogenation. 88 
 89 
Rumen inertness technologies for dietary supplements vary widely in their effectiveness 90 
(especially for highly unsaturated oils), but lipid composite gels may offer a practical solution 91 
(Gadeyne et al., 2016). These gels comprise of an aqueous protein-lipid emulsion which is 92 
heat-treated to induce gelatinisation (Rosenberg and DePeters, 2010), and have been used to 93 
successfully increase milk PUFA content in dairy cows (Carroll et al., 2006; Heguy et al., 2006) 94 
and goats (Weinstein et al., 2016). Comparison with calcium salts has demonstrated that whey 95 
protein gel was more effective at enhancing milk PUFA concentration (Heguy et al., 2006).  96 
 97 
The objectives of this study were to assess the effect of feeding a whey protein composite gel 98 
of rapeseed oil on feed intake, milk yield and composition, and milk FA profile in lactating 99 
Holstein cows. These objectives were addressed in two experiments; experiment 1 was a pilot 100 
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study to compare the effects of whey protein gel of rapeseed oil with those of unprotected 101 
rapeseed oil, with the hypothesis was that the whey protein gel supplement would minimise 102 
rumen exposure of the unsaturated FA in rapeseed oil, and therefore result in lower milk TFA 103 
concentration than an unprotected rapeseed oil supplement.  Experiment 2 was conducted to 104 
determine effects of feeding increasing amounts of the whey protein gel of rapeseed oil 105 
supplement on milk production and composition.  106 
 107 
MATERIALS AND METHODS 108 
Experiment 1 109 
Experimental design, animals and management. All experimental procedures used 110 
were licensed, regulated and inspected by the UK Home Office under the Animals (Scientific 111 
Procedures) Act, 1996. Four multiparous Holstein cows of mean (± standard error) parity of 112 
3.5 (± 0.25), milk yield of 39.2 (± 1.55) kg/d, and 86.2 (± 19.88) DIM were used in a 113 
changeover study lasting 21 days in total, with 8-d treatment periods. Animals were randomly 114 
allocated to one of two treatments (2 cows each) for 8 days (period 1). This was followed by a 115 
5 day “wash-out” period when animals reverted to the pre-trial diet, then animals switched 116 
dietary treatments for another 8 days (period 2). Cows were housed in a cubicle yard with 117 
rubber chip filled mattresses and wood shavings as required as additional bedding. In the 118 
cubicle yard individual feeding was achieved using an electronic identification system and 119 
pneumatic feed barrier (Insentec, Marknesse, the Netherlands). Clean water was constantly 120 
available via a water trough. Cows were milked through a conventional herringbone parlour 121 
twice daily at 06:00 and 16:00h.    122 
 123 
Experimental diets. Diets were offered as TMR (forage:concentrate ratio 53:47 on a 124 
DM basis) with the forage consisting of maize and grass silage, hay and straw (267, 209, 36 125 
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and 18 g/kg DM respectively; Table 1). Treatments consisted of additional rapeseed oil (RO; 126 
TMR plus the addition of 420 g food grade RO/d) or whey protein gel of rapeseed oil (WPG; 127 
TMR plus the addition of 1400 g WPG/d).  Supplements were included incrementally so that 128 
140, 280, and 420 g  of RO or 467, 933 and 1400 g of WPG was fed on days 1, 2 and 3-8, 129 
respectively. The RO diet also included added whey protein isolate (UltraWhey 80, Volac 130 
International Ltd., Royston, UK; 55, 111 and 167 g for days 1, 2 and 3-8, respectively) to 131 
balance the WPG protein content. RO, WPG and whey protein isolate were added to the TMR 132 
so that the concentrations of other TMR ingredients were diluted. The WPG supplement was 133 
prepared using the methods of (Carroll et al., 2006); whey protein isolate (UltraWhey 80, Volac 134 
International Ltd., Royston, UK; composition: DM 955 g/kg fresh weight, protein, fat, lactose 135 
and ash 820, 70, 40 and 35 g/kg DM, respectively) was dissolved in tap water at 40°C to create 136 
a 17% (w/v) whey protein solution. This was mixed (Silverson L4RT High Shear Mixer, 137 
Silverson Machines Inc., MA, USA) with food grade RO for 5 minutes to yield a product 138 
containing approximately 30% oil (fresh weight basis). This mixture was homogenised twice 139 
using a single stage high-pressure homogeniser (Rannie, No 2786/54, 100 bar), and the 140 
resulting whey protein/rapeseed oil emulsion decanted into 400 g food cans, sealed under 141 
vacuum, and heat-treated at 120°C for 138 min (Fraser static steam retort, John Fraser & Sons 142 
Ltd., Newcastle-upon-Tyne, UK). This created a gel which contained (on a DM basis) 720 g/kg 143 
oil and 280 g/kg whey protein. Following heat treatment, the cans were allowed to cool and 144 
stored sealed at 2°C until further use, which was within one month. For feeding, the gel was 145 
removed from the can, roughly chopped and mixed with the concentrate portion of the diet 146 
using a hand-held rotary paint mixer immediately before TMR preparation. The RO and whey 147 
protein isolate were added in a similar manner. During the wash-out period, a basal TMR was 148 
fed containing no supplemental fat (Table 1).  Cows were offered diets as equal meals at 0830 149 
and 1600 h.  150 
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 151 
Experimental sampling. Prior to the addition of WPG, RO or whey protein isolate, a 152 
bulked sample of the basal TMR was taken for nutrient composition and fatty acid (FA) 153 
analysis, and stored at -20°C. A sample of the WPG and RO were retained for subsequent FA 154 
analysis. Refused feed was removed and weighed daily; fresh weights were recorded and on 155 
day 8 of each period a composite of the refused feed was dried at 60C for 48 h to determine 156 
individual daily DM intakes.  157 
 158 
Milk yield was recorded daily throughout the study. Samples of milk for the determination of 159 
composition by mid-infrared spectral (MIRS) analysis were collected at each milking 160 
throughout the experiment and preserved with potassium dichromate (1 mg/ml; Lactabs; 161 
Thompson and Capper, Runcorn, UK). Additional samples of unpreserved milk were collected 162 
(am + pm) at the beginning and end of each period (days 1 and 8 from periods 1 and 2), stored 163 
at -20ºC, composited according the milk yield, and used for FA analysis.  164 
 165 
Chemical analysis. The fatty acid profile of RO was analysed using a modified version of the 166 
one step transesterification method of Sukhija & Palmquist, (1988). Briefly, 50 mg oil was 167 
incubated with an internal standard (1 mg methyl heneicosanoate, Sigma Aldrich Company 168 
Ltd., Dorset, UK) at 60°C in the presence of 0.4 M sulphuric acid in methanol and toluene as 169 
an extraction solvent, for 2 h (oil) or 3 h (TMR). Following neutralisation, the resulting fatty 170 
acid methyl esters (FAME) in toluene were allowed to stand over sodium sulphate for 30 min 171 
to remove methanol residues before being quantified by gas chromatography (GC; Bruker 350, 172 
Bruker, Germany). The GC was equipped with a flame ionisation detector and 100 m fused 173 
silica capillary column (CP-SIL 88, Agilent Technologies, Cheshire, UK), and GC conditions 174 
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were as published previously (Kliem et al., 2013). FA were quantified using internal standard 175 
peak area, and the results were expressed as g/100 g FA. 176 
 177 
Milk fat, crude protein, lactose, urea and casein were determined by MIRS (Foss Electric Ltd., 178 
York, UK) as described previously (Kliem et al., 2008). Milk samples taken at the beginning 179 
and end of each period were analysed for FA profile according to the method of Kliem et al. 180 
(2013a). Briefly, lipid in 1 ml thawed, warmed (to 40°C) milk was extracted in duplicate using 181 
a mixture of diethyl ether and hexane (IDF 1: 2010 [E], International Dairy Federation, 2010, 182 
Brussels, Belgium) and extracts were transesterified to FAME according to previously 183 
described procedures (Kliem et al., 2013a). GC conditions and FAME identification were as 184 
described above. Carbon deficiency in the flame ionization detector response for FAME 185 
containing 4- to 10-carbon atoms was accounted for using a combined correction factor which 186 
also converted FAME to FA (Ulberth et al., 1999). All milk FA results were expressed as g 187 
/100 g total FA. 188 
 189 
Data analysis. Milk yield, DMI, and milk FA concentrations on day 8 of each period 190 
and the difference between days 1 and 8 for each period were analysed (n=8) using the mixed 191 
procedure of SAS (Version 9.4, SAS Institute Inc., Cary, NC). The model tested fixed effects 192 
of treatment and period, and random effect of cow, with period as a repeated effect within cow. 193 
Compound symmetry, heterogeneous compound symmetry, first-order autoregressive, 194 
heterogeneous first-order regressive or an unstructured covariance structure was used for 195 
repeated measures analysis, based on goodness of fit criteria for each variable analysed. Least 196 
squares mean results for day 8 and differences between days 1 and 8 are reported. Differences 197 
were deemed significant when P < 0.05. 198 
 199 
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Experiment 2 200 
 201 
Experimental design, animals and management. Four multiparous Holstein-Friesian 202 
cows of mean (± standard error) parity 2.5 (± 0.25), milk yield 42.6 ( ± 0.90) litres/day and 116 203 
(± 1.2) days in lactation were used in a balanced 4 x 4 Latin square design experiment with 14 204 
day periods. Cows were housed as in Experiment 1. Cows were milked through a conventional 205 
herringbone parlour twice daily at 06:00h and 16:00h.    206 
 207 
Experimental diets. Diets were offered as a TMR (Forage:concentrate ratio 50:50 on a 208 
DM basis) with the forage consisting of maize silage and grass silage (750 and 250 g/kg of 209 
forage dry matter respectively; Table 2). Treatments consisted of a control diet containing no 210 
supplemental lipid (control) or the same basal diet with whey protein gel fed at incremental 211 
inclusion rates calculated to supply 300, 600 and 900 g oil/d  (WPG300, WPG600, WPG900, 212 
respectively) at a predicted DMI of 25 kg/d. The whey protein gel replaced cracked wheat in 213 
the TMR. This whey protein gel supplement was manufactured slightly differently to before, 214 
in that larger (2.9 kg capacity) food cans were used for the heat treatment, and a higher capacity 215 
homogenizer (Rannie 12-16.50 Lab Homogeniser) was used to facilitate preparation of a larger 216 
batch. WPG was added to the concentrate portion of the diet as before, prior to TMR mixing. 217 
Varying amounts of whey protein were added such that the total amount of whey protein 218 
(regardless of treatment) was the same for each diet on a DM basis (Table 1). Diets were 219 
formulated to be isonitrogenous. Cows were offered diets as equal meals at 0900 and 1600 h. 220 
Uneaten feed was removed and weighed prior to the morning feed. 221 
 222 
Experimental sampling. Individual forage components of experimental diets and the 223 
TMR were sampled daily over the last four days of each period. Oven DM contents were 224 
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determined daily by drying at 100C for 23 h to allow for adjustments of fresh weight inclusion 225 
rates and to ensure that the DM composition of experimental diets was maintained. Straw and 226 
concentrate components were sampled over the same time, and composited. Refused feed was 227 
removed and weighed daily; fresh weights were recorded and during measurement weeks 228 
(week two of each period) a weekly composite of the refused feed was dried at 60C for 48 h 229 
to determine individual daily DM intakes. Samples of rapeseed oil and whey protein gel were 230 
retained at -20C for subsequent chemical analysis. 231 
 232 
Milk yield was recorded daily and samples of milk for composition and FA analysis were taken 233 
as outlined in Experiment 1.  234 
 235 
Chemical analysis. Samples of each forage, concentrate, whey protein gel and rapeseed 236 
oil were analysed for OM, CP, NDF, ADF, starch and water soluble carbohydrate content 237 
according to reference procedures outlined previously (Kliem et al., 2008). The TMR ME 238 
values were predicted using equations derived from neutral cellulase plus gamanase 239 
digestibility (MAFF, 1993). Milk fat, crude protein, lactose, urea and casein were determined 240 
by MIRS analysis as described previously. Lipids in 1 ml of milk and appropriate weights of 241 
forage, concentrate, whey protein gel and rapeseed oil samples were analysed as in Experiment 242 
1.  243 
 244 
Data analysis. Averages of DMI, FA intake, milk production, milk composition and 245 
milk FA concentrations for each cow and treatment (n=16) were analysed using the mixed 246 
procedure of SAS (version 9.4, SAS Institute Inc., Cary, NC) and a model testing fixed effects 247 
of treatment and period, and random effects of cow, with period as a repeated effect within 248 
cow. Data analysed were averaged for the last 4 days of each period (with the exception of milk 249 
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FA concentration).  Compound symmetry, heterogeneous compound symmetry, first-order 250 
autoregressive, heterogeneous first-order regressive or an unstructured covariance structure 251 
was used for repeated measures analysis, based on goodness of fit criteria for each variable. 252 
Orthogonal contrasts were used to test for linear, quadratic and cubic effects of whey protein 253 
gel inclusion. Differences were deemed significant when P < 0.05. 254 
 255 
RESULTS 256 
Experiment 1 257 
The composition of the basal TMR used in Experiment 1 is presented in Table 1. The rapeseed 258 
oil comprised of 60 g/100 g cis-9 18:1, 19 g/100 g 18:2 n-6, 8 g/100 g 18:3 n-3, 5 g/100 g 16:0 259 
and 2 g/100 g 18:0 (cis-13 22:1 content of 0.01 g/100 g). Inclusion of either RO or WPG in the 260 
diet had no effect (P > 0.05) on DMI or milk, fat or protein yield (Table 2). There was no 261 
obvious observed selection against the WPG supplement. Supplementing cow diets with either 262 
RO or WPG had very few effects on individual milk FA (Table 3; Supplementary Table 1). 263 
Due to the lack of resolution of chromatogram peaks only total CLA was reported, although 264 
this will have been predominantly cis-9, trans-11 CLA. Milk fat 16:0 concentration was lower 265 
(P = 0.036) after 8 days of WPG supplementation compared with RO, but the difference 266 
between days 0 and 8 for WPG was not different (P = 0.474). This may have influenced the 267 
total SFA concentration, which was numerically (P = 0.088) lower after WPG compared with 268 
RO supplementation. Supplementation had an effect on TFA concentration in milk fat; RO 269 
supplementation increased (P = 0.015) trans-9 16:1 concentration to a greater extent than WPG 270 
(Table 3), after 8 days. In addition, WPG milk fat concentrations of trans-6-8 16:1 and several 271 
trans-18:1 isomers (trans-11 18:1, trans-12 18:1; Table 3, Supplementary Table 1) were 272 
numerically lower compared with RO. This contributed to an overall lower (P = 0.002) total 273 
trans MUFA content after 8 days of supplementation with WPG compared with RO (Table 3). 274 
12 
 
There was no difference (P = 0.140) in total TFA between the two treatments after 8 days, but 275 
the increase observed in total TFA for both treatments was greater (P = 0.031) for the RO 276 
treatment (Table 3). Supplementation had no effect on most PUFA, apart from total CLA 277 
(Table 3) and trans-11, cis-15 18:2 (Supplementary Table 1) which was numerically higher 278 
following RO supplementation. 279 
 280 
Experiment 2 281 
Diets were formulated so that the WPG supplement replaced cracked wheat in the TMR (Table 282 
1), thus predicted ME concentration increased with increasing WPG inclusion (Table 2). The 283 
rapeseed oil comprised of 61 g/100 g cis-9 18:1, 18 g/100 g 18:2 n-6, 9 g/100 g 18:3 n-3, 5 284 
g/100 g 16:0 and 2 g/100 g 18:0. 285 
 286 
Incremental inclusion of WPG resulted in a cubic effect (P = 0.008) on DMI, which was 287 
decreased by 0.5 kg/d at the highest inclusion level (WPG900; Table 4). As with Experiment 288 
1, there was no observed selection against the WPG supplement. WPG caused a linear increase 289 
(P < 0.01) in 16:0, 18:0, cis-9 18:1, 18:2 n-6, 18:3 n-3 and total FA intake (Table 4). 290 
Incremental inclusion of WPG linearly increased (P = 0.002) milk yield (Table 4). There was 291 
also a linear (P = 0.007) decrease in milk fat concentration when WPG was included 292 
incrementally (Table 4).  293 
 294 
WPG supplementation linearly decreased (P < 0.01) most short- and medium-chain SFA, apart 295 
from 4:0 and 6:0 (Table 5). Milk fat concentration of 16:0 was decreased (P < 0.001) by 38 % 296 
when comparing control vs WPG900 (Table 5). Linear effects were also observed for 16:1 FA, 297 
with the WPG diets linearly increasing (P < 0.05) trans-6-8, trans-9 and trans-11-13 16:1, and 298 
decreasing (P < 0.01) cis-9, cis-11 and cis-13 16:1 (Table 5). There was a tendency for WPG 299 
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supplementation to linearly increase (P = 0.087) milk fat 18:0 concentration (Table 5). 300 
Incremental inclusion of WPG linearly increased (P < 0.05) total CLA, 18:3 n-3, 20:0, cis-8 301 
20:1, cis-11 20:1 and 20:3 n-3, and linearly decreased (P < 0.05)  20:3 n-6, 20:4 n-6 and 20:5 302 
n-3 (Table 5).  303 
 304 
In terms of MUFA, increasing WPG supplementation resulted in linear increases (P < 0.05) in 305 
most trans- and cis-18:1 isomers identified (Table 6). In milk from control-fed cows, the 306 
predominant trans-18:1 isomer was trans-11 18:1. However, with increasing WPG inclusion, 307 
trans-10 18:1 became the predominant isomer (Table 6). This isomer showed a tendency (P = 308 
0.057) to linearly increase with increasing WPG inclusion (Table 6). Milk fat concentration of 309 
cis-9 18:1 linearly increased (P < 0.001) by almost 60 % when comparing control with 310 
WPG900 (Table 6). Linear increases in cis-11 and cis-13 18:1 were also observed. Increasing 311 
WPG inclusion linearly increased (P < 0.05) cis-9, trans-13, cis-9, trans-12, trans-9, cis-12, 312 
trans-11, cis-15 and cis-9, cis-12 18:2 isomers (Table 7).  313 
 314 
DISCUSSION 315 
Feeding cis-MUFA rich plant oil sources to dairy cows is effective at replacing milk fat SFA 316 
with cis-MUFA (Kliem & Shingfield, 2016). However this dietary strategy also causes an 317 
increase in milk fat concentration of TFA. Research continues into protection technologies to 318 
minimise rumen exposure of dietary unsaturated fatty acids, but many are not cost effective or 319 
are inconsistent in their effectiveness (Jenkins and Bridges, 2007). Formation of whey protein 320 
composite gels, where oil is emulsified with an aqueous whey protein phase before being heat 321 
treated to form a solid gel matrix, offers one option for rumen protection (Gadeyne et al., 2016). 322 
As well as optimising the amount of unsaturated FA available for absorption by the cow, rumen 323 
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protection of oils also minimises undesirable effects of unsaturated oils on the rumen microbial 324 
environment. 325 
 326 
In Experiment 1, supplementing lactating cows with 420 g rapeseed oil as either unprotected 327 
oil or WPG had little impact on intake, milk yield and milk composition. Previous studies 328 
supplementing cows with similar quantities of unprotected rapeseed oil also reported no effect 329 
on milk yield or protein composition (Rego et al., 2009; Halmemies-Beauchet-Filleau et al., 330 
2011), but a decrease in milk fat content was observed when 500 g/d was fed over 28 d (Rego 331 
et al., 2009). Experiment 1 was very short-term in comparison, which may in part explain the 332 
lack of impact of rapeseed oil or WPG on milk yield and component concentration. Other 333 
shorter duration studies supplementing lactating cows with similar quantities of rapeseed oil 334 
(DePeters et al., 2001) or WPG of sunflower oil (Carroll et al., 2006) reported similar results 335 
in terms of milk yield and composition. 336 
 337 
Experiment 2 involved incremental supplementation of WPG, with treatments providing 271, 338 
617 and 814 g supplemental rapeseed oil/d, over longer experimental periods. The slight 339 
decrease in DMI with incremental WPG inclusion observed may reflect increased post-ruminal 340 
supply of lipid, especially at the higher inclusion level, where DMI was lower than control. 341 
Drackley et al. (2007) reported decreased DMI when high oleic acid sunflower oil was infused 342 
directly into the abomasum (bypassing the rumen), concluding that free MUFA decrease DMI 343 
in a dose-dependent manner. Similarly, Benson and Reynolds (2001) observed a decrease in 344 
DMI in cows infused into the abomasum with 400 g rapeseed oil daily, which was associated 345 
with an increase in blood concentrations of anorexic gut peptides.  It is not known if there was 346 
dissociation of lipid from the WPG in the rumen, but at higher intake levels it is possible that 347 
some dissociation occurred, which would have a negative impact on the rumen environment 348 
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(Lock and Shingfield, 2004). Previous research involving whey protein gel complexes of 349 
unsaturated oils reported no difference in DMI when compared with control diets containing 350 
unprotected oils, but these involved lower supplementation levels (Carroll et al., 2006; Heguy 351 
et al., 2006). 352 
 353 
Increasing WPG inclusion in Experiment 2 increased milk yield substantially, despite the small 354 
decrease in DMI due to WPG feeding. The WPG incrementally replaced wheat in the diet, 355 
increasing the calculated ME content of the treatment diets. A previous study involving 356 
incremental supplementation of dairy cow diets with a rumen inert (calcium salt) rapeseed oil 357 
reported no effect on milk yield, despite an increase in ME concentration of the diets (Kliem 358 
et al., 2013b). This discrepancy may be due to stage of lactation; in the current study cows were 359 
at an earlier stage of lactation, when more of their dietary energy is partitioned towards milk 360 
energy output (Kirkland and Gordon, 2001). 361 
 362 
Consistent with previous research involving incremental inclusion of unsaturated oils in dairy 363 
cow diets, the WPG600 and WPG900 treatment diets resulted in a decrease in milk fat 364 
concentration, whilst milk fat concentration was increased by WPG300 (cubic effect). The 365 
decrease in milk fat concentration at higher levels of supplementation is in part due to a dilution 366 
effect of increased milk yield, as milk fat yield was not affected.  In addition, dietary 367 
unprotected oils rich in unsaturated fatty acids can decrease milk fat concentration (Glasser et 368 
al., 2008), partially due to a negative impact on the rumen environment (Lock and Shingfield, 369 
2004), but also due to the inhibition of milk fat synthesis by longer chain unsaturated FA 370 
(Barber et al., 1997). The effect on milk fat concentration indicate that at higher 371 
supplementation levels there may have been some dissociation of lipid from the whey protein 372 
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complex, and/or a greater proportion of cis-9 18:1, 18:2 n-6 and 18:3 n-3 from the rapeseed oil 373 
reaching the mammary gland. 374 
 375 
There were very few differences in milk fat SFA concentration with supplementation of RO 376 
compared to WPG in Experiment 1, which is contrary to the results of Carroll et al. (2006) who 377 
fed 3 cows a whey protein isolate gel or a whey protein concentrate gel of soybean oil for 8 378 
days and observed a significant decrease in 16:0 concentration that accompanied increases in 379 
18:2 n-6 and 18:3 n-3 concentrations in milk fat. At the end of the supplementation period, 380 
16:0 concentration was lower with WPG than RO, but as there was no difference in change 381 
over time this is probably due to a lower day 1 concentration for WPG. Total SFA tended to be 382 
lower with WPG, and the WPG supplement appeared to have little effect on change in SFA. 383 
This suggests at the inclusion level used for the short supplementation time both RO and WPG 384 
had little impact on milk SFA concentration. Other studies involving similar inclusion levels 385 
of rapeseed oil supplemented for longer periods. Rego et al. (2009) supplemented grazing cows 386 
with 500 g/d rapeseed oil for 28 d, and reported significant decreases in the milk fat 387 
concentration of short and medium chain SFA compared with a control diet containing no oil. 388 
Jacobs et al. (2011) reported lower concentrations of some SFA in milk fat from cows 389 
supplemented with 408 g/d rapeseed oil for 23 d, compared with a control post-trial period 390 
lasting 28 d. In Experiment 2, even the lowest level of WPG inclusion (WPG300) resulted in a 391 
13% decrease (P = 0.003) in milk fat concentration of 16:0, which contributed to a lower total 392 
SFA, compared with Control. At the higher intake levels, the effect of WPG inclusion on 8:0, 393 
10:0, 12:0, 14:0 and 16:0 was consistent with previous studies involving rapeseed oil. Kliem 394 
et al. (2011) supplemented cow diets with 750, 1000 or 1250 kg/d rapeseed oil in the form of 395 
milled rapeseed, and reported linear decreases in 6:0, 8:0, 10:0, 12:0, 14:0 and 16:0. In the 396 
current study, 16:0 concentration was decreased more than 13 g/100 g FA, which was a similar 397 
17 
 
response to that observed when calcium salts of rapeseed oil were supplemented at similar oil 398 
levels (Kliem et al., 2013b). Around half of the 16:0 in milk fat is derived from mammary de 399 
novo synthesis, with the remainder being supplied by the circulation (Hawke and Taylor, 1995). 400 
The WPG supplement contained 13 g/100 g FA 16:0, so incremental WPG inclusion increased 401 
16:0 intake. Therefore the decrease in milk fat 16:0 is certainly related to inhibition of 402 
mammary de novo synthesis. In contrast to the study of Kliem et al. (2013b) an increase in milk 403 
18:0 concentration was not observed, despite an increased 18:0 intake. Milk fat 18:0 usually 404 
increases following supplementation with 18-carbon MUFA and/or PUFA-rich oilseeds 405 
(Glasser et al., 2008) following complete biohydrogenation of these FA. The lack of change in 406 
milk 18:0 indicates that unsaturated FA in the rapeseed oil present in WPG may have been 407 
afforded some protection from rumen biohydrogenation. Carroll et al. (2006) compared 408 
different whey protein gel of sunflower oil preparations, and reported no difference in milk fat 409 
18:0 concentrations when compared with control diets containing no oil.  410 
 411 
The decreased milk SFA concentration observed when supplementing cow diets with rapeseed 412 
oil is generally balanced by an increase in both cis- and trans-MUFA (Glasser et al., 2008; 413 
Kliem and Shingfield, 2016). Milk fat cis-9 18:1 is derived from dietary sources, and also from 414 
desaturation of 18:0 by mammary Δ9 desaturase. In Experiment 1, the shorter supplementation 415 
time led to no change in milk cis-9 18:1 (or total cis-MUFA) concentration for both the RO 416 
and WPG diets. In Experiment 2, there was a linear increase in cis-9 18:1 concentration, which 417 
was reflected in total cis-MUFA. This cis-9 18:1 increase was not as high as some studies have 418 
observed for unprotected rapeseed oil, when calculated on a per weight rapeseed oil consumed 419 
(1.0 vs 1.7 g/100 g FA increase per 100 g oil from Rego et al., 2009), but was higher than others 420 
(Givens et al., 2009; Jacobs et al.,2011) . WPG also linearly increased milk fat concentration 421 
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of minor cis-18:1 isomers, such as cis-11, cis-13 and cis-16 18:1. These isomers have been 422 
identified as biohydrogenation intermediates of PUFA such as 18:2 n-6 (Jouany et al., 2007). 423 
 424 
One of the main goals for creating rumen inert supplements of unsaturated oils is to minimise 425 
increases in milk fat TFA concentration, which are formed as intermediates of cis-MUFA and 426 
PUFA biohydrogenation in the rumen. The longer WPG supplementation period of Experiment 427 
2 resulted in an increased concentration of most trans-18:1 and 18:2 isomers identified, and 428 
these concentrations increased linearly with incremental WPG inclusion. Trans-11 18:1 is 429 
generally the most abundant trans-18:1 in milk fat, and is a common intermediate of 18:2 n-6 430 
and 18:3 n-3 metabolism in the rumen (Palmquist et al., 2005). In addition to trans-11 18:1, in 431 
vitro studies have shown that biohydrogenation of cis-9 18:1 by rumen microorganisms can 432 
yield a range of trans-18:1 isomers, including trans-9, trans-10 and trans-12 18:1, some of 433 
which can be further isomerised (Mosley et al., 2002). The highest supplementation level in 434 
Experiment 2 resulted in trans-10 18:1 being the predominant trans-18:1 isomer. This isomer 435 
can increase following altered rumen fermentation in response to certain diets, resulting in a 436 
shift in 18:2 n-6 biohydrogenation pattern (Bauman et al., 2011). It has been implicated as a 437 
possible causative factor in milk fat depression, although abomasal infusion studies report 438 
inconsistent results (Shingfield et al., 2009). Intake of 18:2 n-6 in Experiment 2 did increase 439 
with incremental inclusion, but not as much as that of cis-9 18:1, so it is probably that some of 440 
the increase in trans-10 18:1 was due to isomerisation of cis-9 18:1. 441 
 442 
Recent research has focused on the concentration of trans-9 16:1 in milk fat, after studies 443 
reported positive associations between circulating concentrations of this FA and human health 444 
(Mozaffarian et al., 2010). Trans-9 16:1 is thought to arise following rumen metabolism of 445 
longer chain PUFA (Shingfield et al., 2012). A human intervention study has reported that 446 
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some trans-9 16:1 may be produced intracellularly following β-oxidation of trans-11 18:1 447 
(Jaudszus et al., 2014). However it is not known if a similar process occurs in bovine cells. In 448 
both experiments, milk concentrations of trans-9 16:1 increased in line with trans-11 18:1. But 449 
as intake of PUFA also increased, it is difficult to say whether milk trans-9 16:1 was derived 450 
from rumen metabolism, or tissue oxidation of trans-11 18:1 from the rumen. 451 
 452 
Results from Experiment 2 demonstrated that increasing supplementation levels of WPG also 453 
increase milk fat concentrations of PUFA. The WPG supplement contained 18:2 n-6 and 18:3 454 
n-3, and incremental inclusion of WPG resulted in linear increases in the concentration of these 455 
FA and their transfer efficiency (18:2 n-6 transfer efficiencies of 0.010, 0.116, 0.118, 0.122, P 456 
= 0.002; 18:3 n-3 transfer efficiencies of 0.075, 0.100, 0.105, 0.109, P = 0.001; for control , 457 
WPG300, WPG600 and WPG900, respectively), suggesting that these PUFA were at least 458 
partially protected from rumen biohydrogenation. These results improve upon previous data 459 
involving unprotected plant oils, which reported transfer efficiencies for 18:2 n-6 and 18:3 n-3 460 
of between 0.08 and 0.10, and 0.07 and 0.09, respectively (Halmemies-Beauchet-Filleau et al., 461 
2011). However, increased concentrations of cis-9, trans-12 18:2 and trans-11, cis-15 18:2 462 
demonstrate that there was some rumen metabolism of 18:2 n-6 (Jouany et al., 2007) and 18:3 463 
n-3 (Harfoot and Hazlewood, 1997). Total CLA also increased with incremental WPG 464 
inclusion, which reflects increased trans-11 18:1 leaving the rumen; most milk cis-9, trans-11 465 
CLA is synthesised by mammary Δ9 desaturase from trans-11 18:1 (Piperova et al., 2002). 466 
 467 
At the highest WPG intake level (814 g rapeseed oil equivalent/d), the increase in total TFA 468 
concentration compared with the control diet per 100 g rapeseed oil consumed was 0.52 g/100 469 
g total FA.  Previous studies from this laboratory have reported varying increases in milk fat 470 
TFA, depending on the rapeseed oil preparation (increases of 0.22 and 1.05 g/100 g total FA 471 
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by Kliem et al. [2011] and Kliem et al., [2013b], respectively). As mentioned previously, the 472 
impact of rTFA on human health and disease risk is not entirely clear, and indeed may be 473 
isomer-specific. Most studies (prospective cohort and intervention) focus on rTFA as a group, 474 
however there is evidence to suggest that consuming butter high in trans-11 18:1 or cis-9, 475 
trans-11 CLA may not increase some CVD risk factors (Tholstrup et al., 2006; Tricon et al., 476 
2006). The effect of trans-11 18:1 may be metered through its endogenous conversion to cis-477 
9, trans-11 CLA (Turpeinen et al., 2002). The effect of other trans isomers on health is not 478 
confirmed, although a butter rich in trans-10 18:1 (which was the predominant isomer in milk 479 
fat from the high WPG treatments in Experiment 2) has been found to increase CVD risk factors 480 
in rabbits when compared with butters rich in trans-11 18:1 and a control (Roy et al., 2007). 481 
The increases in TFA observed in the current studies would be unlikely to have much of an 482 
impact on human health; a previous calculation demonstrated that in order to exceed the 483 
maximum recommended level of 2 % EI (SACN, 2007) by changing dairy fatty acid profile 484 
alone, would mean producing milk fat containing 17 g/100 g fatty acids (Kliem et al., 2013). 485 
However, until isomer-specific effects on human health can be confirmed, increases in rTFA 486 
in milk and ruminant meat should be minimised. 487 
 488 
In conclusion, results from the current study suggest that protection of rapeseed oil by the whey 489 
protein gel matrix may help to minimise milk TFA concentrations when compared with 490 
unprotected rapeseed oil. In addition, WPG is more effective than calcium salts of rapeseed oil 491 
FA investigated previously by this group, in terms of minimising milk TFA concentrations. 492 
Protection of unsaturated vegetable oils using a lipid composite gel may provide a viable 493 
approach to optimising beneficial FA uptake by the cow. 494 
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